PB2498: A PHASE 1 STUDY OF WU-NK-101 IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)

• Amanda Cashen,
• Ashkan Emadi,
• Edward Abadir,
• Monzr Al Malki,
• Peter Tan,
• Joshua Zeidner,
• Natasha Edwin,
• Peter Sayre,
• Lori Muffly,
• John Muth,
• Kenneth Jacobs,
• Ouiam Bakkacha,
• Eileen Mcnulty,
• Angela Pannunzio,
• Jan Davidson-Moncada

Affiliations

Amanda Cashen

1 Washington University School of Medicine, St. Louis, United States

Ashkan Emadi

2 University of Maryland Medical School, Baltimore, United States

Edward Abadir

3 Royal Prince Alfred, Camperdown, NSW, Australia

Monzr Al Malki

4 City of Hope, Duarte, United States

Peter Tan

5 Royal Perth Hospital, West Perth, Australia

Joshua Zeidner

6 University of North Carolina Healthcare, Chapel Hill, United States

Natasha Edwin

7 Providence, Portland, United States

Peter Sayre

8 University of California San Francisco Health, San Francisco, United States

Lori Muffly

9 Stanford Medicine, Palo Alto, United States

John Muth

10 Wugen, St. Louis, United States

Kenneth Jacobs

10 Wugen, St. Louis, United States

Ouiam Bakkacha

10 Wugen, St. Louis, United States

Eileen Mcnulty

10 Wugen, St. Louis, United States

Angela Pannunzio

10 Wugen, St. Louis, United States

Jan Davidson-Moncada

10 Wugen, St. Louis, United States